The primary end-point event (myocardial infarction/stroke) in 305 patients on alogliptin therapy was 11.3% in comparison with placebo (11.8%) (hazard ratio, 0.96
Absence of large-scale clinical trials, delaying regulatory approvals and mainstream adoption (McGleenon et al., 1999)
When you introduce a concentrated source of sulfur, like glutathione, it can fuel these bacteria, leading to the production of excess gas
Blood-brain barrier dysfunction in the detrimental brain function, in Connectivity and Functional Specialization in the Brain , ed HeinbockelT
In 2006, researchers experimented on three groups of rats two controls and one intervention and observed that the group that received the Selank intervention exhibited significantly reduced anxiety-phobic states that persisted throughout the four-week study period